keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Tuesday, August 12th, 2025 - Day 1 - EST/EDT (Eastern Daylight, GMT-4)
keyboard_arrow_leftSearch & Filter
search
Free / Premium
Tuesday, August 12th, 2025 - Day 1 - EST/EDT (Eastern Daylight, GMT-4)
search
Free / Premium
Showing 1 of 1 Streams
Networking Break
9:00am - 10:00am
Registration & Continental Breakfast
Showing 1 of 1 Streams
General Session
Free 10:00am - 10:15am
Informa Connect Welcome and Chair's Opening Remarks
- Dawn DiPierro - Director, Global Compliance Operations, Insmed
10:15am - 11:15am
CMS Townhall
Discuss the latest developments and trends with US transparency reporting requirements and updates to the Open Payments platform.
- Veronika Peleshchuk Fradlin - Director of Transparency & Data Group, Centers for Medicare and Medicaid Services (CMS)
- Kathleen Ott - Open Payments Compliance Lead, Centers for Medicare & Medicaid Services (CMS)
11:15am - 12:15pm
Enforcement Update – Examining Today’s Regulatory Landscape and Emerging Trends
- Analyze the current regulatory landscape and recent enforcement actions impacting the life sciences industry
- Gain insights into upcoming areas of regulatory focus for 2025 and beyond
- Understand the latest guidance and expectations for effective compliance programs
- Amanda Masselam Strachan - Partner, WilmerHale
- Lauren Kootman - Principal Assistant Chief, Corporate Enforcement & Compliance Unit, Fraud Section, Criminal Division, U.S. Department of Justice
- Ari Fontecchio - Chief, Health Care Fraud and Opioid Enforcement Unit, U.S. Attorney’s Office, District of New Jersey
Showing 1 of 1 Streams
Networking Break
12:15pm - 1:30pm
Networking Luncheon
Showing 1 of 1 Streams
General Session
Free 1:30pm - 2:00pm
PhRMA Industry Update
- Gain insights into the evolving landscape of state legislative issues affecting the bio/pharmaceutical sector
- Explore advancements in state-level pharmaceutical transparency laws throughout the 2025 legislative cycle
- Merlin Brittenham - Assistant General Counsel, Pharmaceutical Research and Manufacturers of America (PhRMA)
2:00pm - 3:00pm
Harnessing Industry Data Analysis for Enhanced Benchmarking and Risk Mitigation – A Case Study
- Discover how a top-tier pharmaceutical company leverages CMS Open Payments data to benchmark practices against industry trends
- Explore innovative strategies and best practices for analyzing HCP engagement trends, including speaker programs and pharmaceutical representative registrations
- Learn how competitive insights empower the company to defend its positions during audits, align with industry standards, and minimize the risk of outlier perception
- Stay ahead of trends to ensure robust compliance, regulatory adherence, and significant risk mitigation in HCP engagement
- Ted Lowery, CFE - Director, External Disclosure and Data Analytics, GSK
Showing 1 of 1 Streams
Networking Break
3:00pm - 3:30pm
Networking & Refreshment Break
Showing 2 of 2 Streams
Foundation Breakout
Benchmarking Breakout
3:30pm - 5:00pm
Transparency & HCP Engagement 101
For those new to the field, this session will provide a comprehensive introduction to the essential principles of transparency reporting and compliant HCP engagements. Topics to be covered include:
- Understand the history and evolution of spend transparency
- Explore key considerations in building an effective reporting program, including identifying various sources of reportable spending
- Emphasize the critical role of regular data audits and the importance of tracing data origins to ensure accuracy and compliance
- Explore the core principles of HCP engagements, including intended purpose and structure, and learn how to identify and mitigate potential risk areas and non-compliance
- Understand the importance of organizational awareness of transparency requirements and how to structure HCP engagement systems to capture necessary data for reporting
Sign up here to secure your spot today to master the fundamentals and advance your career.
- G. Melissa Ince - Director, Global Transparency, Abbott Laboratories
- Maria Villanueva - Head of Compliance, BioTissue
3:30pm - 5:00pmFree
Interactive Roundtable Review of Pre-Conference Survey
This session will provide a comprehensive review of the pre-conference benchmarking survey results. Attendees will engage in facilitated roundtable discussions to delve into the data, identify trends, and share best practices. Gain valuable insights into industry benchmarks and contribute to a collaborative learning environment.
- Rawan Fusisi - Head, I&C Global Transparency and Analytics, Indivior
- Peter Christopulos - Senior Director, Global Transparency Reporting, Johnson & Johnson
Showing 1 of 1 Streams
Networking Break
5:00pm - 6:00pm
Close of Day One and Networking Reception
Filter
Free / Premium